QQQ   310.34 (+1.43%)
AAPL   159.28 (+1.19%)
MSFT   273.78 (+0.57%)
META   202.16 (+2.20%)
GOOGL   104.92 (+3.66%)
AMZN   100.61 (+2.97%)
TSLA   197.58 (+7.82%)
NVDA   261.99 (+1.15%)
NIO   9.27 (+5.94%)
BABA   83.70 (+3.33%)
AMD   95.93 (-0.91%)
T   18.54 (+0.27%)
F   11.72 (+4.83%)
MU   58.63 (+1.72%)
CGC   1.97 (+5.91%)
GE   92.18 (+2.51%)
DIS   96.54 (+2.46%)
AMC   4.41 (+3.28%)
PFE   40.66 (-0.37%)
PYPL   76.72 (+4.79%)
NFLX   305.79 (+0.22%)
QQQ   310.34 (+1.43%)
AAPL   159.28 (+1.19%)
MSFT   273.78 (+0.57%)
META   202.16 (+2.20%)
GOOGL   104.92 (+3.66%)
AMZN   100.61 (+2.97%)
TSLA   197.58 (+7.82%)
NVDA   261.99 (+1.15%)
NIO   9.27 (+5.94%)
BABA   83.70 (+3.33%)
AMD   95.93 (-0.91%)
T   18.54 (+0.27%)
F   11.72 (+4.83%)
MU   58.63 (+1.72%)
CGC   1.97 (+5.91%)
GE   92.18 (+2.51%)
DIS   96.54 (+2.46%)
AMC   4.41 (+3.28%)
PFE   40.66 (-0.37%)
PYPL   76.72 (+4.79%)
NFLX   305.79 (+0.22%)
QQQ   310.34 (+1.43%)
AAPL   159.28 (+1.19%)
MSFT   273.78 (+0.57%)
META   202.16 (+2.20%)
GOOGL   104.92 (+3.66%)
AMZN   100.61 (+2.97%)
TSLA   197.58 (+7.82%)
NVDA   261.99 (+1.15%)
NIO   9.27 (+5.94%)
BABA   83.70 (+3.33%)
AMD   95.93 (-0.91%)
T   18.54 (+0.27%)
F   11.72 (+4.83%)
MU   58.63 (+1.72%)
CGC   1.97 (+5.91%)
GE   92.18 (+2.51%)
DIS   96.54 (+2.46%)
AMC   4.41 (+3.28%)
PFE   40.66 (-0.37%)
PYPL   76.72 (+4.79%)
NFLX   305.79 (+0.22%)
QQQ   310.34 (+1.43%)
AAPL   159.28 (+1.19%)
MSFT   273.78 (+0.57%)
META   202.16 (+2.20%)
GOOGL   104.92 (+3.66%)
AMZN   100.61 (+2.97%)
TSLA   197.58 (+7.82%)
NVDA   261.99 (+1.15%)
NIO   9.27 (+5.94%)
BABA   83.70 (+3.33%)
AMD   95.93 (-0.91%)
T   18.54 (+0.27%)
F   11.72 (+4.83%)
MU   58.63 (+1.72%)
CGC   1.97 (+5.91%)
GE   92.18 (+2.51%)
DIS   96.54 (+2.46%)
AMC   4.41 (+3.28%)
PFE   40.66 (-0.37%)
PYPL   76.72 (+4.79%)
NFLX   305.79 (+0.22%)
NASDAQ:PLSE

Pulse Biosciences - PLSE Stock Forecast, Price & News

$3.08
+0.09 (+3.01%)
(As of 03/21/2023 12:00 AM ET)
Add
Compare
Today's Range
$2.98
$3.13
50-Day Range
$2.52
$3.88
52-Week Range
$1.18
$5.46
Volume
37,690 shs
Average Volume
51,500 shs
Market Capitalization
$114.67 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$11.17

Pulse Biosciences MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
262.6% Upside
$11.17 Price Target
Short Interest
Bearish
12.80% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.60
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.88 out of 5 stars

Medical Sector

686th out of 983 stocks

Surgical & Medical Instruments Industry

64th out of 100 stocks


PLSE stock logo

About Pulse Biosciences (NASDAQ:PLSE) Stock

Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments uses a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Hayward, CA.

Receive PLSE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pulse Biosciences and its competitors with MarketBeat's FREE daily newsletter.

PLSE Stock News Headlines

The gold catalyst we’ve waited for
If you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK.
Earnings Preview: Pulse Biosciences
The gold catalyst we’ve waited for
If you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK.
Pulse Biosciences, Inc. (PLSE)
Recap: Pulse Biosciences Q2 Earnings
See More Headlines
Receive PLSE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pulse Biosciences and its competitors with MarketBeat's FREE daily newsletter.

PLSE Company Calendar

Last Earnings
11/15/2021
Today
3/21/2023
Next Earnings (Confirmed)
3/30/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:PLSE
Fax
N/A
Employees
142
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$11.17
High Stock Price Forecast
$13.00
Low Stock Price Forecast
$8.50
Forecasted Upside/Downside
+262.6%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

Net Income
$-63,660,000.00
Net Margins
-2,866.34%
Pretax Margin
-4,167.67%

Debt

Sales & Book Value

Annual Sales
$1.42 million
Book Value
$1.20 per share

Miscellaneous

Free Float
16,753,000
Market Cap
$114.67 million
Optionable
Optionable
Beta
1.11

Key Executives

  • Kevin Danahy
    President & Chief Executive Officer
  • Edison Manuel
    Vice President-Operations
  • Darrin R. Uecker
    Chief Technology Officer
  • David Danitz
    Senior Vice President-Engineering
  • Richard Nuccitelli
    Chief Science Officer













PLSE Stock - Frequently Asked Questions

Should I buy or sell Pulse Biosciences stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Pulse Biosciences in the last twelve months. There are currently 3 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" PLSE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PLSE, but not buy additional shares or sell existing shares.
View PLSE analyst ratings
or view top-rated stocks.

What is Pulse Biosciences' stock price forecast for 2023?

3 brokerages have issued 12 month target prices for Pulse Biosciences' shares. Their PLSE share price forecasts range from $8.50 to $13.00. On average, they predict the company's share price to reach $11.17 in the next year. This suggests a possible upside of 262.6% from the stock's current price.
View analysts price targets for PLSE
or view top-rated stocks among Wall Street analysts.

How have PLSE shares performed in 2023?

Pulse Biosciences' stock was trading at $2.77 on January 1st, 2023. Since then, PLSE stock has increased by 11.2% and is now trading at $3.08.
View the best growth stocks for 2023 here
.

When is Pulse Biosciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 30th 2023.
View our PLSE earnings forecast
.

How can I listen to Pulse Biosciences' earnings call?

Pulse Biosciences will be holding an earnings conference call on Thursday, March 30th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

How were Pulse Biosciences' earnings last quarter?

Pulse Biosciences, Inc. (NASDAQ:PLSE) announced its earnings results on Monday, November, 15th. The company reported ($0.48) earnings per share for the quarter, topping the consensus estimate of ($0.53) by $0.05. The company had revenue of $0.57 million for the quarter. Pulse Biosciences had a negative net margin of 2,866.34% and a negative trailing twelve-month return on equity of 290.24%. During the same period last year, the firm posted ($0.51) earnings per share.

What is Darrin R. Uecker's approval rating as Pulse Biosciences' CEO?

2 employees have rated Pulse Biosciences Chief Executive Officer Darrin R. Uecker on Glassdoor.com. Darrin R. Uecker has an approval rating of 100% among the company's employees. This puts Darrin R. Uecker in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Pulse Biosciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pulse Biosciences investors own include Advanced Micro Devices (AMD), AbbVie (ABBV), Bausch Health Companies (BHC), Wayfair (W), Achaogen (AKAO), NVIDIA (NVDA), Portola Pharmaceuticals (PTLA), Enphase Energy (ENPH) and Novavax (NVAX).

When did Pulse Biosciences IPO?

(PLSE) raised $20 million in an initial public offering on Wednesday, May 18th 2016. The company issued 5,000,000 shares at $4.00 per share. MDB Capital Group and Feltl and Company acted as the underwriters for the IPO.

What is Pulse Biosciences' stock symbol?

Pulse Biosciences trades on the NASDAQ under the ticker symbol "PLSE."

Who are Pulse Biosciences' major shareholders?

Pulse Biosciences' stock is owned by a number of institutional and retail investors. Top institutional investors include Griffin Asset Management Inc. (0.47%), Geode Capital Management LLC (0.37%), Westside Investment Management Inc. (0.37%), Susquehanna International Group LLP (0.00%), Advisor Group Holdings Inc. (0.18%) and Millennium Management LLC (0.12%). Insiders that own company stock include Kevin Patrick Danahy, Maky Zanganeh and Mitchell E Levinson.
View institutional ownership trends
.

How do I buy shares of Pulse Biosciences?

Shares of PLSE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Pulse Biosciences' stock price today?

One share of PLSE stock can currently be purchased for approximately $3.08.

How much money does Pulse Biosciences make?

Pulse Biosciences (NASDAQ:PLSE) has a market capitalization of $114.67 million and generates $1.42 million in revenue each year. The company earns $-63,660,000.00 in net income (profit) each year or ($2.03) on an earnings per share basis.

How many employees does Pulse Biosciences have?

The company employs 142 workers across the globe.

How can I contact Pulse Biosciences?

Pulse Biosciences' mailing address is 3957 POINT EDEN WAY, HAYWARD CA, 94545. The official website for the company is www.pulsebiosciences.com. The company can be reached via phone at (510) 906-4600 or via email at ir@pulsebiosciences.com.

This page (NASDAQ:PLSE) was last updated on 3/21/2023 by MarketBeat.com Staff